Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy (Q34344188)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy (English)

1 reference

Europe PubMed Central

1 August 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

object named as

G Bodoky

5

0 references

Bengt Glimelius

3

object named as

B Glimelius

1 reference

Europe PubMed Central

1 August 2017

author name string

J Bernhard

1

1 reference

Europe PubMed Central

1 August 2017

D Dietrich

2

1 reference

Europe PubMed Central

1 August 2017

V Hess

4

1 reference

Europe PubMed Central

1 August 2017

W Scheithauer

6

1 reference

Europe PubMed Central

1 August 2017

R Herrmann

7

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

28 September 2010

1 reference

Europe PubMed Central

1 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

1 August 2017

103

1 reference

Europe PubMed Central

1 August 2017

9

1 reference

Europe PubMed Central

1 August 2017

1318-1324

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605929

0 references

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

The prognostic significance of patient-reported outcomes in cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

Clinical relevance of single item quality of life indicators in cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

On the receiving end. IV: Validation of quality of life indicators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

6 July 2018

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605929

21 January 2018

The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

27 October 2018

Performance characteristics of five automated CA 19-9 assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990612

27 October 2018

The prevalence of psychological distress by cancer site

1 reference

https://pubmed.ncbi.nlm.nih.gov/20877359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20877359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

1 reference

https://pubmed.ncbi.nlm.nih.gov/20877359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European organization for research and treatment of cancer quality of life questionnaire: implications for prognosis in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20877359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605929

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34344188&oldid=1521354108"